# Alantos Pharmaceuticals

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/alantos-pharmaceuticals

- Industry: Biotechnology
- Headquarters: Heidelberg, Germany
- Total disclosed funding: $20M
- Latest round: Series B (Mar 10, 2005)
- Investors on record: 6

## About

Founded in 1999, Alantos Pharmaceuticals is a bio-pharmaceutical company, which develops small molecule drugs for type 2 diabetes and osteoarthritis/inflammation based diseases.

## Funding rounds

- Series B, Mar 10, 2005, $20M — Oxford Bioscience Partners, Ventech, Heidelberg Innovation Funds Management, SV Health Investors, Earlybird, Capital A

## Investors

- Oxford Bioscience Partners (https://capitalatlas.ai/funds/oxford-bioscience-partners) — Series B
- Ventech (https://capitalatlas.ai/funds/ventech) — Series B
- Heidelberg Innovation Funds Management (https://capitalatlas.ai/funds/heidelberg-innovation-funds-management) — Series B
- SV Health Investors (https://capitalatlas.ai/funds/sv-health-investors) — Series B
- Earlybird (https://capitalatlas.ai/funds/earlybird) — Series B
- Capital A — Series B